Inactive Instrument
Checkmate Pharmaceuticals, Inc. Stock
Stocks
CMPI
US1628181083
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 2018-12-11 | |
Robert Landry
DFI | Director of Finance/CFO | 62 | 2022-05-30 |
Chris French
CTO | Chief Tech/Sci/R&D Officer | - | 2016-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Nouhad Husseini
BRD | Director/Board Member | - | 2022-05-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/31/22 | Issuer sale | Director | 30,030 | 0.1388% | ||
| 5/31/22 | Issuer sale | Director | 20,061 | 0.0927% | ||
| 5/31/22 | Issuer sale | Chief Executive Officer | 575,000 | 2.6583% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.38% | - | - | 231M | |
| +1.23% | +0.35% | +51.62% | +87.98% | 55.92B | |
| +2.03% | +8.06% | +64.49% | +69.68% | 56.67B | |
| -1.80% | -0.90% | -20.87% | -15.29% | 23.28B | |
| -0.20% | -1.99% | +2.55% | +418.87% | 23.28B | |
| -0.36% | +5.73% | +30.99% | -3.58% | 20.54B | |
| -0.91% | +0.45% | +24.96% | -30.31% | 17.78B | |
| -1.44% | +5.67% | +32.54% | +544.11% | 15.9B | |
| -2.54% | -8.73% | +164.11% | +289.45% | 14.64B | |
| -0.26% | -0.75% | +23.91% | +179.03% | 13.99B | |
| Average | -0.42% | +1.26% | +41.59% | +171.10% | 26.89B | |
| Weighted average by Cap. | +0.20% | +3.18% | +43.18% | +136.55% |
Employees
31
